SIRT6 and hepatocellular carcinoma: It was shown that SIRT6 functions as a tumor suppressor in hepatocellular carcinoma (HCC) through the binding and deacetylating of nuclear pyruvate kinase M2 (PKM2), which suppresses the oncogenic functions of PKM2, resulting in decreased cancer cell proliferation, migration, and invasiveness [37].